Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Depreciation & Amortization (CF) (2017 - 2026)

Cogent Biosciences' Depreciation & Amortization (CF) history spans 10 years, with the latest figure at $626000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 2.19% to $626000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Mar 2026, up 1.77% year-over-year, with the annual reading at $2.6 million for FY2025, 4.0% up from the prior year.
  • Depreciation & Amortization (CF) came in at $626000.0 for Q1 2026, down from $664000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $675000.0 in Q4 2024 to a low of $69000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $606000.0 (2024), against an average of $519176.5.
  • Year-over-year, Depreciation & Amortization (CF) skyrocketed 666.67% in 2023 and then decreased 2.19% in 2026.
  • Cogent Biosciences' Depreciation & Amortization (CF) stood at $378000.0 in 2022, then surged by 66.14% to $628000.0 in 2023, then rose by 7.48% to $675000.0 in 2024, then dropped by 1.63% to $664000.0 in 2025, then fell by 5.72% to $626000.0 in 2026.
  • Per Business Quant, the three most recent readings for COGT's Depreciation & Amortization (CF) are $626000.0 (Q1 2026), $664000.0 (Q4 2025), and $641000.0 (Q3 2025).